Addex Therapeutics Statistics
Total Valuation
ADXN has a market cap or net worth of $8.49 million. The enterprise value is $6.48 million.
| Market Cap | 8.49M |
| Enterprise Value | 6.48M |
Important Dates
The next estimated earnings date is Monday, June 15, 2026, before market open.
| Earnings Date | Jun 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADXN has 147.83 million shares outstanding. The number of shares has increased by 9.44% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 147.83M |
| Shares Change (YoY) | +9.44% |
| Shares Change (QoQ) | +4.62% |
| Owned by Insiders (%) | 15.05% |
| Owned by Institutions (%) | 1.46% |
| Float | 123.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 38.93 |
| Forward PS | n/a |
| PB Ratio | 1.41 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 29.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.40 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,162.64 |
Financial Efficiency
Return on equity (ROE) is -94.75% and return on invested capital (ROIC) is -24.23%.
| Return on Equity (ROE) | -94.75% |
| Return on Assets (ROA) | -20.64% |
| Return on Invested Capital (ROIC) | -24.23% |
| Return on Capital Employed (ROCE) | -54.49% |
| Weighted Average Cost of Capital (WACC) | 15.06% |
| Revenue Per Employee | $108,998 |
| Profits Per Employee | -$4.24M |
| Employee Count | 2 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.65% in the last 52 weeks. The beta is 1.97, so ADXN's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | -27.65% |
| 50-Day Moving Average | 6.66 |
| 200-Day Moving Average | 7.85 |
| Relative Strength Index (RSI) | 43.13 |
| Average Volume (20 Days) | 2,357 |
Short Selling Information
The latest short interest is 4,982, so 0.46% of the outstanding shares have been sold short.
| Short Interest | 4,982 |
| Short Previous Month | 5,006 |
| Short % of Shares Out | 0.46% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.95 |
Income Statement
In the last 12 months, ADXN had revenue of $217,996 and -$8.49 million in losses. Loss per share was -$0.08.
| Revenue | 217,996 |
| Gross Profit | -629,032 |
| Operating Income | -3.55M |
| Pretax Income | -8.63M |
| Net Income | -8.49M |
| EBITDA | -3.55M |
| EBIT | -3.55M |
| Loss Per Share | -$0.08 |
Balance Sheet
The company has $2.07 million in cash and $43,746 in debt, with a net cash position of $2.02 million or $0.01 per share.
| Cash & Cash Equivalents | 2.07M |
| Total Debt | 43,746 |
| Net Cash | 2.02M |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 6.01M |
| Book Value Per Share | 0.04 |
| Working Capital | 606,797 |
Cash Flow
| Operating Cash Flow | -2.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 530 |
| Net Borrowing | -9,138 |
| Free Cash Flow | -2.72M |
| FCF Per Share | -$0.02 |
Margins
| Gross Margin | -288.55% |
| Operating Margin | -1,628.25% |
| Pretax Margin | -3,958.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADXN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.44% |
| Shareholder Yield | -9.44% |
| Earnings Yield | -99.99% |
| FCF Yield | -32.00% |
Analyst Forecast
The average price target for ADXN is $30.00, which is 383.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $30.00 |
| Price Target Difference | 383.87% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 23, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 23, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
ADXN has an Altman Z-Score of -78.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -78.3 |
| Piotroski F-Score | 1 |